相关实验视频
Updated: Jun 21, 2025

07:34
Manual Therapy for a Chronic Non-Specific Low Back Pain Rat Model
Published on: August 11, 2023
681
评估临床试验报告的透明度调查手动治疗干预措施的腰部疼痛:一个方法论审查
Jennifer C Junkin1, Derek Vraa1, Jodi L Young1
1Department of Physical Therapy Program, Bellin College, Green Bay, Wisconsin, USA.
Journal of evaluation in clinical practice
|July 8, 2024
概括
对腰部疼痛 (LBP) 的手动治疗试验显示透明度较差. 许多研究缺乏注册,试验注册和出版之间的显著结果差异表明潜在的偏见,影响LBP治疗证据.
科学领域:
- 临床试验方法论 临床试验方法论
- 基于证据的医学基于证据的医学.
- 肌肉骨系统疾病 肌肉骨系统疾病
背景情况:
- 腰部疼痛 (LBP) 构成了全球相当大的健康负担.
- 手动治疗是对LBP的推治疗方法,得到大量文献的支持.
- 对手动治疗研究的方法质量和报告透明度存在担忧.
研究的目的:
- 评估LBP手动治疗临床试验的报告透明度.
- 将注册数据库中的计划试验组件与已发表的手稿数据进行比较.
- 确定差异,并评估LBP手动治疗研究的整体透明度.
主要方法:
- 通过对三个数据库的系统搜索,确定了对LBP手动治疗的试验 (2005年1月 - 2023年5月).
- 包括的干预措施包括推力操纵,动员或肌肉能量技术.
- 试验注册与已公布的结果进行了比较,重点是初级和二级终点.
主要成果:
- 在包括的167项研究中,仅有87项 (52.1%) 被注册,其中57项是前性的.
- 在注册和出版之间,在37.9%的初级结果和69%的二次结果中发现了差异.
- 只有4.6%的注册试验详细说明了统计分析计划,而在21.8%的试验中引用了CONSORT指南.
结论:
- 在试验注册和预期注册率方面发现了显著的差距.
- 注册和公布结果之间的差异引发了人们对LBP手动治疗研究中的潜在偏见的担忧.
- 加强期刊提交要求和明确报告差异对于提高LBP手动治疗试验透明度至关重要.
更多相关视频
06:28Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
472
05:10Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain
Published on: August 30, 2022
2.7K
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K